Non-invasive Neuromodulation NESA Application in the Rehabilitation of Stroke Sequelae
ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Las Palmas de Gran Canaria
About this trial
To evaluate whether NESA microcurrents can be used as an effective treatment for various sequelae present in stroke patients, specifically in the treatment of spasticity, balance, pain; and whether it affects quality of life, performance of activities of daily living and quality of sleep.
Eligibility criteria
Qualifiers
People who have suffered a stroke with an evolution between 6 months and 6 years.
Optimal cognitive capacity and mentally competent to participate in the study and complete the required questionnaires.
People able of standing upright, including those who need technical aids.
Disqualifiers
Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, not to apply electrodes on skin in bad condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or phobia to electricity.
Not having signed the informed consent form.
Presenting any additional injury or pathology during the study.
Not having the optimal cognitive capacities for understanding and participating in the study.
Trial design
Treatments tested in this trial
- Non-invasive Neuromodulation
- Placebo Non-invasive Neuromodulation
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov